Innoviz Technologies Ltd. (INVZ) develops high-performance solid-state LiDAR sensors and perception software for automotive, robotics, and defense uses, based in Israel. Coverage on this Nasdaq Capital Market micro-cap has declined sharply as the share price has dropped. The two most recent attributable targets are Goldman Sachs at $0.75 with a Neutral/Hold rating from around April 2026 and Amerx at $3.00 with a Buy rating from May 2026. Their average comes to roughly $1.88, which I round to the $1.90 central target referenced here.
This figure is not an official consensus. Different aggregators show varying numbers, some near $0.40 and others near $0.75, owing to differences in methods and time frames, along with much outdated historical coverage. The $0.75–$3.00 spread is notably broad and points to two distinct narratives: Goldman’s more cautious stance highlights near-term automotive execution risks, while Amerx’s higher target captures the potential from the defense pivot. Both targets predate the company’s November 2026 report, where management sharply reduced full-year guidance, so they may not yet incorporate the latest financial details.
The stock closed near $0.18 on November 11, 2026, following a sharp post-earnings drop. A move to $1.90 would imply an increase of roughly 955%, a very large shift even for a volatile small-cap name. It trades near the low end of its 52-week range of about $0.13 to $1.76 and is down more than 80% over the trailing year, with a market capitalization of only about $52 million and roughly 288 million shares outstanding.
For the target to become attainable, the company would need to restore revenue growth and show a believable route to positive gross margins and reduced cash burn. The third-quarter results complicate that outlook: revenue of $12.1 million missed expectations, a key customer moved start-of-production and non-recurring engineering milestone payments into 2027, and full-year 2026 revenue guidance was lowered to $44–$46 million from $67–$73 million.
The most visible potential catalyst is the company’s move into defense and homeland security with its Perciz line. Management indicated defense accounted for about 10% of third-quarter revenue and could reach 20–30% of sales in 2027, with average selling prices an order of magnitude higher than automotive LiDAR. Recognition of its sensors by Israel’s MAFAT research directorate and counter-UAS discussions at the AUSA 2026 conference offer early validation, though no large orders are assured.
A roughly 20% workforce reduction, expected to deliver about $17.5 million in annualized savings, aims to extend the cash runway into 2028. The company held about $54.4 million in liquidity with no long-term debt, while automotive programs with partners such as Volkswagen and Daimler Truck remain in development even as timing shifts.
The most immediate challenge is weakening core economics. Gross margin was negative 10.3% in the third quarter, net losses widened to $19.6 million, and quarterly cash burn rose to about $21.4 million. The guidance reduction indicates that a key customer’s production delay is moving substantial NRE revenue out of 2026. The company also raised roughly $27.8 million in equity during the quarter, and its share count has increased about 18% year over year, diluting existing shareholders.
Outside fundamentals, the defense narrative is still unproven: MAFAT recognition is not a procurement commitment, and turning evaluations into volume orders remains uncertain. For a company of this scale, ongoing losses, possible future capital raises, and competition in both LiDAR and defense sensing continue to weigh against a re-rating toward the higher end of the analyst range.
The stock is testing the lower end of its 52-week range, with the 52-week low near $0.13 acting as a key support level. A sustained break below it would leave little chart-based support. On the upside, the recent breakdown area around $0.22 and the 50-day moving average near $0.30 represent near-term resistance. Given the size of the move to $1.90, the target lies well above any meaningful technical reference and is not indicated by current chart structure.
Analyst price targets generally reflect a roughly 12-month research horizon, though the specific horizon for these two targets was not disclosed. The most important items to watch are whether the delayed automotive program’s NRE payments arrive in 2027, whether defense orders convert from evaluations to bookings, and whether gross margin trends toward breakeven. Quarterly cash burn, any additional equity issuance, and analyst target revisions following the November guidance cut are also worth tracking. Investors should monitor the next earnings report and any updates on program wins and the Perciz pipeline.
I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how the stock compares to others in the industry. Tickeron’s AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile, low-priced name like Innoviz, this kind of tool can help traders surface opportunities, keep an eye on existing positions, and identify shifting trends more efficiently than manual screening. Traders interested in a systematic, data-driven view of daily market moves can explore the AI Daily Buy/Sell Signals to complement their own research.
Reaching $1.90 would require Innoviz Technologies to recover roughly 955% from a price near $0.18, a very large move with little support from current fundamentals or technical structure. The central target, an average of the two most recent analyst price targets of $0.75 and $3.00, reflects genuine analyst disagreement rather than a reliable forecast. The bullish case rests on the defense pivot and cost reductions; the bearish case rests on a revenue guidance cut, negative gross margin, accelerating cash burn, and continued dilution. Neither the $1.90 figure nor any individual target should be treated as a prediction, and investors should monitor program timing, defense order conversion, and cash runway before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for INVZ turned positive on November 06, 2026. Looking at past instances where INVZ's MACD turned positive, the stock continued to rise in 38 of 43 cases over the following month. The odds of a continued upward trend are 88%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where INVZ's RSI Oscillator exited the oversold zone, 42 of 53 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 62 cases where INVZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +13.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where INVZ advanced for three days, in 188 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
INVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INVZ as a result. In 68 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The 10-day moving average for INVZ crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for INVZ entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.285) is normal, around the industry mean (0.781). P/E Ratio (-0.553) is within average values for comparable stocks, (39.881). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.494). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (1.236) is also within normal values, averaging (49.456).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. INVZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INVZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AutoPartsOEM